Ivermectin, a small molecule drug, operates as a modulator of the glutamate-gated chloride channel, an action that forms the basis of its pharmacological activity.

PharmAbcine Initiates Dosing in Early-Stage Study for PMC-309 with KEYTRUDA (pembrolizumab) in Subjects Facing Severe Solid Cancers.

Prednisone is a widely-used corticosteroid drug for treating inflammatory conditions such as allergies, arthritis, and asthma, working by suppressing the immune system to reduce inflammation.

Harbour BioMed has been granted FDA approval to initiate human trials for their bispecific antibody, HBM9027, in the U.S.

Amlodipine is a calcium channel blocker medication designed to treat hypertension and angina. It works by relaxing blood vessels and promoting blood flow.

Tramadol is a prescription painkiller used for moderate to severe pain relief. It works by binding to opioid receptors in the brain and spinal cord, reducing pain perception.

Biosion has received approval from the FDA for its investigational new drug application concerning BSI-082, an innovative monoclonal antibody targeting SIRPα.

Sertraline, a widely used SSRI drug for treating depression, anxiety, and OCD in adults and children, affects brain neurotransmitter interactions.

CDR-Life revealed the FDA's approval for clinical trial application for their drug, CDR404, aimed at addressing solid tumor conditions.

Doxycycline is a tetracyclin-like broad-spectrum antibiotic that stops bacteria from growing and replicating by inhibiting the synthesis of bacterial proteins.

Omeprazole, a common PPI, is used to treat gastrointestinal conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome.

Long-term results show Opdivo combined with Yervoy outlasts Sunitinib in survival outcomes for advanced or metastatic kidney cancer patients who haven't received prior treatment over an 8-year period.